News Briefs

  ניסן 20, 5774 , 20/04/14

Teva Setback: Competitors Can Sell Copaxone, Court Says

A U.S. Supreme Court Justice on Friday rejected a petition by Israeli pharmaceutical maker Teva to prevent competitors from producing generic versions of multiple sclerosis drug Copaxone while hearings go on to extend the patent. The rejection of Teva's request means that competitors, including Mylan, Momenta Pharmaceuticals, and Novartis AG’s Sandoz could start selling generic versions of the drug as soon as next month.
Other archived news briefs:Apr 20 2014, 03:54 PM, 4/20/2014